Some of the world’s leading researchers in type 1 and type 2 diabetes will gather March 14-17 for City of Hope’s 10th Annual Rachmiel Levine Diabetes and Obesity Symposium. Titled “Advances in Diabetes Biology, Immunology and Cell Therapy,” the event will be held at Caesars Palace in Las Vegas.
|Immunohistochemical staining of pancreatic tissue shows insulinproducing cells in green and glucagon-producing cells in red. (Photo by Courtesy of Fouad Kandeel)|
The four-day program will focus in part on islet biology, including beta cell regeneration. It also will cover islet immunology, including advances in understanding autoimmunity and the role of inflammation in causing diabetes. Researchers will discuss promising new treatment strategies, including efforts to create a closed-loop (“artificial pancreas”) system that would link a blood-glucose sensor to an insulin pump.
The meeting also will explore the genetic basis of type 1 and type 2 diabetes and offer insights into the metabolic effects of bariatric surgery and gestational diabetes. It will offer technical workshops in islet biology and updates on recent diabetes clinical trials, as well.
At the opening dinner, City of Hope will honor major philanthropist and business leader T. Denny Sanford with the President’s Award for his support of biomedical research and patient care.
The event is organized by the Leslie and Susan Gonda (Goldschmied) Diabetes and Genetics Research Center, the Southern California Islet Cell Resources Center and the Juvenile Diabetes Research Foundation Islet Cell Transplant Center at City of Hope.
Levine Symposium registration fees increase on March 8. For details, visit www.levinesymposium.com.